Literature DB >> 23232501

Loss of substance P and inflammation precede delayed neurodegeneration in the substantia nigra after cerebral ischemia.

Beatriz Rodriguez-Grande1, Victoria Blackabey1, Beatrice Gittens1, Emmanuel Pinteaux2, Adam Denes3.   

Abstract

Focal cerebral ischemia leads to delayed neurodegeneration in remote brain regions. The substantia nigra (SN) does not normally show primary neuronal death after ischemic events affecting the striatum, but can exhibit delayed neuronal loss after the ischemic injury through mechanisms that are unknown. No data are available in mice showing acute post-stroke inflammation and remote injury in the SN. Substance P (SP), a mediator of neurogenic inflammation, is a key element of the striato-nigral circuitry, but alterations of SP in the SN have not been studied after acute striatal injury. Inflammation, a key contributor to neuronal death, is found in the SN after striatal ischemia, but it is unknown whether it precedes or occurs concomitantly with neuronal death. We hypothesised that focal striatal ischemia induces changes in SP levels in the SN and that inflammation precedes neuronal death in the SN. Using the middle cerebral artery occlusion model, we found a significant loss of SP in the ipsilateral SN 24h after striatal ischemia in mice. In the same area where SP loss occurs, significant glial and vascular activation, but no neuronal death, were observed. In contrast, a marked neuronal loss was observed within six days in the area of SP loss and inflammation. Our data suggest that focal loss of SP and early inflammatory changes in the SN precede remote neuronal injury after striatal ischemic damage. These observations may have important implications for motor impairment in stroke patients and indicate that striatal ischemia might facilitate Parkinson's disease development.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232501     DOI: 10.1016/j.bbi.2012.11.017

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  30 in total

Review 1.  Deep brain stimulation: are astrocytes a key driver behind the scene?

Authors:  Albert J Fenoy; Laurent Goetz; Stéphan Chabardès; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2014-01-24       Impact factor: 5.243

2.  Determination of Brain-Regional Blood Perfusion and Endogenous cPKCγ Impact on Ischemic Vulnerability of Mice with Global Ischemia.

Authors:  Shuiqiao Liu; Qingqing Dai; Rongrong Hua; Ting Liu; Song Han; Shujuan Li; Junfa Li
Journal:  Neurochem Res       Date:  2017-06-08       Impact factor: 3.996

3.  MRI heralds secondary nigral lesion after brain ischemia in mice: a secondary time window for neuroprotection.

Authors:  Vincent Prinz; Anna-Maria Hetzer; Susanne Müller; Mustafa Balkaya; Christoph Leithner; Golo Kronenberg; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

4.  Mitochondrial and calcium perturbations in rat CNS neurons induce calpain-cleavage of Parkin: Phosphatase inhibition stabilizes pSer65Parkin reducing its calpain-cleavage.

Authors:  Hu Wang; Fanny Cheung; Anna C Stoll; Patricia Rockwell; Maria E Figueiredo-Pereira
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-02-21       Impact factor: 5.187

5.  Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real-World Cohort.

Authors:  David M Kent; Lester Y Leung; Eric J Puttock; Andy Y Wang; Patrick H Luetmer; David F Kallmes; Jason Nelson; Sunyang Fu; Chengyi Zheng; Ellen M Vickery; Hongfang Liu; Alastair J Noyce; Wansu Chen
Journal:  Ann Neurol       Date:  2022-08-17       Impact factor: 11.274

Review 6.  The delta-opioid receptor and Parkinson's disease.

Authors:  Jin-Zhong Huang; Yi Ren; Yuan Xu; Tao Chen; Terry C Xia; Zhuo-Ri Li; Jian-Nong Zhao; Fei Hua; Shi-Ying Sheng; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2018-08-03       Impact factor: 5.243

7.  Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction.

Authors:  Ming Gan; Simon Moussaud; Peizhou Jiang; Pamela J McLean
Journal:  Neurobiol Aging       Date:  2014-11-05       Impact factor: 4.673

8.  Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L-Dopa-induced dyskinesia in parkinsonian rats.

Authors:  Shetty Ravi Dyavar; Lisa F Potts; Goichi Beck; Bhagya Laxmi Dyavar Shetty; Benton Lawson; Anthony T Podany; Courtney V Fletcher; Rama Rao Amara; Stella M Papa
Journal:  Genes Brain Behav       Date:  2020-09-11       Impact factor: 3.449

9.  PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.

Authors:  Kai-Yvonne Shivers; Anastasia Nikolopoulou; Saima Ishaq Machlovi; Shankar Vallabhajosula; Maria E Figueiredo-Pereira
Journal:  Biochim Biophys Acta       Date:  2014-06-23

Review 10.  Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases.

Authors:  Koji Kamagata; Christina Andica; Ayumi Kato; Yuya Saito; Wataru Uchida; Taku Hatano; Matthew Lukies; Takashi Ogawa; Haruka Takeshige-Amano; Toshiaki Akashi; Akifumi Hagiwara; Shohei Fujita; Shigeki Aoki
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.